OpenAI Trial Reveals Internal Turmoil, ‘Terminator’ Safety Fears
SAN FRANCISCO — A federal trial between Elon Musk and OpenAI has produced testimony revealing internal dysfunction and AI safety fears among insiders likened to the “Terminator” film franchise, The New York Times reported.
The trial, which centers on Musk’s claims that OpenAI abandoned its founding nonprofit mission, has produced testimony about deep disagreements among OpenAI’s leadership over the company’s direction, safety protocols and corporate governance, The Times reported.
Among the revelations emerging from the courtroom: internal communications showing that some OpenAI personnel raised alarm about the existential risks of advanced AI systems — fears serious enough to invoke the “Terminator” scenario of machines turning against humanity — as the company pursued increasingly powerful models.
In a separate but related development reported by CNBC, Musk allegedly offered OpenAI CEO Sam Altman a seat on the Tesla board during the period in question, adding another layer to the complicated personal and professional relationship between the two tech figures at the center of the dispute.
The trial’s outcome could have implications for OpenAI’s planned transition from a nonprofit to a for-profit corporate structure — a move that has drawn scrutiny from regulators, rival companies and AI safety advocates. OpenAI has argued the restructuring is necessary to attract the capital required to compete in the AI industry.
Musk, who co-founded OpenAI in 2015 as a nonprofit research lab before departing the board in 2018, has alleged the company breached its original charter by prioritizing commercial interests over its mission to develop AI for the benefit of humanity. OpenAI has denied those claims, contending that Musk’s lawsuit is driven by competitive interests tied to his own AI venture, xAI.
The testimony regarding internal dysfunction underscores tensions within OpenAI, including the November 2023 boardroom events that briefly ousted Altman before he was reinstated days later. That episode, which drew attention across the AI industry and Silicon Valley, centered on similar disputes over safety and the pace of commercialization.
The federal case is being closely watched across the technology and legal sectors, as its resolution could set precedent for how AI companies structure themselves and balance safety commitments against the demands of rapid growth and investor expectations.
